QL1706 trials for Breast cancer

All QL1706 trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying QL1706 for Breast cancer

• Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
  NCT07180160 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
  NCT06786026 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer
  NCT06967103 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study QL1706 for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.